The World Health Organisation (WHO) says it has requested more data from the makers of Covaxin, before it can be listed for emergency use.
In a series of Tweet, the WHO explained that the timeframe for Covaxin’s Emergency Use Listing was dependent on how quickly the vaccine manufacturers were able to provide the required data.
“We are aware that many people are waiting for WHO’s recommendation for Covaxin to be included in the #COVID19 Emergency Use Listing, but we cannot cut corners,” the WHO said on Twitter.
The global health agency further emphasized that it cannot “cut corners” to approve the Covaxin vaccine, adding that it must thoroughly ensure the safety of the drug.
The WHO said that once “the information provided addresses all questions raised”, the organisation and its Technical Advisory Group would “complete the assessment and come to a final recommendation whether to grant Emergency Use Listing to the vaccine”.